Personalized Antisense Oligonucleotide for A Single Participant With ATN1 Gene Mutation
Personalized Antisense Oligonucleotide for A Single Participant With ATN1 Gene Mutation
Active, not recruiting · NCT07084311 · Registry updated 2026-07-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Personalized Antisense Oligonucleotide for A Single Participant With ATN1 Gene Mutation | Epilepsies, Myoclonic, Epilepsy, Generalized, Epileptic Syndromes, brain disorder, central nervous system disorder, dentatorubral-pallidoluysian atrophy, epilepsy, nervous system disorder, progressive myoclonus epilepsy | Active, not recruiting | Phase 1 / Phase 2 | 2026-07-13 | NCT07084311 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hawaii Pacific Neuroscience | 1 |
| n-Lorem Foundation | 18 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hawaii Pacific Neuroscience | Honolulu | United States | 20 |